Many men and women suffer from red and oily skin, in various skin areas, especially between the eyebrows, sides of the nose and the edge of the forehead and scalp. The causes of this common condition, called Seborrhea, include an inherited predisposition, a plurality of pityrosporum ovale skin fungus, local inflammation and the thickening layer of skin scale. The situation described above can be relieved by using medications containing steroids. Although these medications may bring temporary relief, long-term use involves multiple side effects.
Objectives: This clinical study was designed to examine the SebaCare100product for red oily skin relief. The product is a clear non steroidal liquid containing non medical natural ingredients, including tea tree oil, chamomile, and salicylic acid.
Methods: The study was performed by Prof. Avner Shemer from the Department of Dermatology , Sheeba Medical Center, and the Sackler Medical School, Tel Aviv University in Israel. After IRB approval, the product has been tested on 25 patients – 16 years old and above volunteers with red and oily skin in two of the following areas: Sides of the nose, between the eyebrows, forehead hair margin, scalp skin. The participants did not have any local or another systemic treatment and agreed to be part of the experiment. Patients suffering from another skin disease or with known allergy to any of the product’s ingredients as well as pregnant or nursing women did not participate in the experiment. The treatment lasted a month during which patients sprayed a little of the product on top of their fingers twice a day, spreading the material over the infected area. In the second month of the experiment, patients continued to use the product twice a week. The volunteers were examined and photographed before treatment, during the second, fourth and eight week of starting treatment. During each treatment session participants were examined and completed a questionnaire assessing treatment efficacy.
Lab experiment: Pityrosporum ovale mycological Cultures (the fungus involved in the pathophysiology of Seborrheic dermatitis) were prepared In laboratory conditions. Various concentrations of Sebacare100 solution were added. Qualitative and quantitative examination proved a significant reduction in number of spores in cultures in which the product was added. Clinical response to treatment was classified according to four levels. 0 = No response 1 – = slight improvement 2 = moderate improvement 3 = an excellent improvement to complete healing.
What were the results of the Study ?
Medical evaluation of the results showed moderate improvement in 93.75 % of patients after 2 weeks of treatment and in 100% of patients after 4 weeks of treatment. Patient self-assessment showed that 80% of patients were satisfied with redness reduction, 90% of patients were satisfied with skin scale reduction, 80% of Patients were satisfied with skin oiliness reduction and 90% of the patients were satisfied with the reduction in skin roughness and scale.
Were side effects involved?
Out of 25 patients recruited for the experiment 22 completed the experiment. Three patients did not complete the experiment due to personal reasons that are independent of the experiment. 20% of patients reported a tingling sensation after product use. The tingling subsided after a few days of product use. Allergy or other side effects were not observed during the experiment.
Summary of results: Researchers have found that SebaCare100 is quite effective in relieving redness, scale and oiliness of the skin in patients suffering from facial and scalp seborrhea. The product is safe for use without remarkable side effects.
For Israeli customers:
Israeli Skin Site
Share on Facebook
Did you like this? Share it: